News Details - novonordisk.com
Jan 8, 2025 · Novo Nordisk and Valo plan to continue working closely together to derive novel insights from human genetic and longitudinal patient data at the intersection of obesity, type 2 diabetes, and cardiovascular disease.
Valo | Valo Health and Novo Nordisk to collaborate to discover …
Sep 24, 2023 · Novo Nordisk and Valo plan to work together to derive novel insights from human genetic and longitudinal patient data in cardiovascular disease.
Valo | Valo Health and Novo Nordisk expand collaboration to …
Jan 8, 2025 · Novo Nordisk and Valo plan to continue working closely together to derive novel insights from human genetic and longitudinal patient data at the intersection of obesity, type 2 diabetes, and cardiovascular disease.
News Details - Novo Nordisk
Sep 25, 2023 · Valo Health and Novo Nordisk to collaborate to discover and develop novel treatments for cardiometabolic diseases using human data and artificial intelligence. Collaboration will apply Valo’s Opal Computational Platform™ and real-world patient dataset to enable the discovery and development of novel cardiometabolic drug programmes
Valo Health and Novo Nordisk expand collaboration to discover …
Jan 8, 2025 · Novo Nordisk A/S Scope of collaboration originally signed in 2023 will significantly expand to enable the discovery and development of up to 20 novel drug programmes in obesity, type 2 diabetes...
Novo Nordisk swells alliance with AI firm Valo Health
Jan 8, 2025 · Novo Nordisk has almost doubled the scale of an R&D alliance with Valo Health – a specialist in applying artificial intelligence to drug discovery – adding up to nine programmes to the original...
Novo Nordisk and Valo expand cardiometabolic drug partnership
Jan 9, 2025 · Novo Nordisk has expanded its partnership with Valo Health to advance new therapies for type 2 diabetes, obesity and cardiometabolic diseases, leveraging AI and extensive human datasets.
Novo Nordisk (NVO), Valo Ink Deal to Develop Heart Disease Drugs
Sep 26, 2023 · Novo Nordisk A/S NVO announced entering into an agreement with Valo Health, Inc. to discover and develop novel treatments for cardiometabolic diseases by utilizing Valo’s large human...
Novo Nordisk Turns to Flagship’s Valo Health for AI ... - MedCity News
Sep 25, 2023 · Novo Nordisk is paying Valo Health $60 million up front to gain three preclinical cardiovascular disease programs. Milestone payments for those programs and others covered under the...
Novo Nordisk expands AI partnership with Valo Health for …
Jan 8, 2025 · Danish drugmaker Novo Nordisk and U.S. tech firm Valo Health said on Wednesday they were expanding their 2023 agreement to develop new treatments for cardiometabolic diseases using human data...